project id: TCGA-PAAD; case submitter id: TCGA-RB-AA9M; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.37; rna integrity number: 8.2; age at index: 43; days to birth: -15807; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1970; age at diagnosis: 15807; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 286.0; icd 10 code: C25.2; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Tail of pancreas; synchronous malignancy: No; tissue or organ of origin: Tail of pancreas; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to collection: 76; days to sample procurement: 0; initial weight: 170.0; portion submitter id: TCGA-RB-AA9M-01A-11; percent lymphocyte infiltration: 8.0; percent monocyte infiltration: 1.0; percent necrosis: 2.0; percent neutrophil infiltration: 1.0; percent normal cells: 4.0; percent stromal cells: 72.0; percent tumor cells: 22.0; percent tumor nuclei: 85.0;